Pure Global

ACTH Quantitative Testing Drug - Vietnam Registration 240002469/PCBB-HCM

Access comprehensive regulatory information for ACTH Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loแบกi B medical device is registered under number 240002469/PCBB-HCM and manufactured by Roche Diagnostics (Suzhou) Ltd.. The authorized representative in Vietnam is Cร”NG TY TNHH ROCHE VIแป†T NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
240002469/PCBB-HCM
Registration Details
Vietnam MOH Registration: 240002469/PCBB-HCM
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

ACTH Quantitative Testing Drug
VN: Thuแป‘c thแปญ xรฉt nghiแป‡m ฤ‘แป‹nh lฦฐแปฃng ACTH
Risk Class TBYT Loแบกi B

Registration Details

240002469/PCBB-HCM

000.00.19.H29-241023-0002

Elecsys ACTH

08946728214

Company Information

Technical Details

In vitro immunoassay test used to quantify the concentration of adrenocorticotropic hormone (ACTH) in human blood plasma, which is anticoagulated with EDTA. The "ECLIA" (electrochemiluminescence immunoassay "ECLIA") test is used in the cobas e immunoassay analyzers.

Dates and Status

Oct 28, 2024